ALIM : Summary for Alimera Sciences, Inc. - Yahoo Finance

U.S. Markets closed

Alimera Sciences, Inc. (ALIM)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.46+0.03 (+2.10%)
At close: 4:00PM EDT

1.46 0.00 (0.00%)
After hours: 5:41PM EDT

People also watch
PSDVACRXANTHAPRIAEGR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.43
Open1.43
Bid1.42 x 2000
Ask1.47 x 1500
Day's Range1.41 - 1.47
52 Week Range1.01 - 2.58
Volume279,201
Avg. Volume663,188
Market Cap94.7M
Beta2.78
PE Ratio (TTM)-2.32
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETFs with exposure to Alimera Sciences, Inc. : April 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube19 days ago

    ETFs with exposure to Alimera Sciences, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cubelast month

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., pSivida Corp., Regeneron Pharmaceuticals, Inc., Insmed Incorporated and Aerie Pharmaceuticals, Inc. (OPHT-US, PSDV-US, REGN-US, INSM-US and AERI-US) that have also reported for ... Read more (Read more...)